Patricia Grambsch

Patricia Grambsch's AcademicInfluence.com Rankings

Patricia Grambsch

Mathematics

#7032

World Rank

#9637

Historical Rank

Statistics

#764

World Rank

#852

Historical Rank

mathematics Degrees

Download Badge

Mathematics

Why Is Patricia Grambsch Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Patricia Louise Meller Grambsch is an American biostatistician known for her work on survival models including proportional hazards models. She is an associate professor emerita of biostatistics at the University of Minnesota.

(See a Problem?)

Patricia Grambsch's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Proportional hazards tests and diagnostics based on weighted residuals (1994) (4766)
A Package for Survival Analysis in S (1994) (4109)
Modeling Survival Data: Extending the Cox Model (2000) (2849)
Martingale-based residuals for survival models (1990) (1065)
Prognosis in primary biliary cirrhosis: Model for decision making (1989) (798)
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. (2003) (723)
Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis (1989) (588)
Penalized Survival Models and Frailty (2003) (433)
Child Sexual Behavior Inventory: Normative and Clinical Comparisons. (1992) (385)
Normative sexual behavior in children. (1991) (331)
The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. (1991) (249)
Primary sclerosing cholangitis: refinement and validation of survival models. (1992) (248)
Primary biliary cirrhosis: Prediction of short‐term survival based on repeated patient visits (1994) (221)
Efficacy of liver transplantation in patients with primary biliary cirrhosis. (1989) (221)
Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial (2001) (218)
The Cox Model (2000) (176)
Diagnostic plots to reveal functional form for covariates in multiplicative intensity models. (1995) (168)
Survival and Event History Analysis: A Process Point of View by AALEN, O. O., BORGAN, O., and GJESSING, H. K. (2009) (167)
Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study. (1996) (146)
Calcium and colorectal epithelial cell proliferation in sporadic adenoma patients: a randomized, double-blinded, placebo-controlled clinical trial. (1995) (145)
Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study. (1990) (123)
Calcium and colorectal epithelial cell proliferation: a preliminary randomized, double-blinded, placebo-controlled clinical trial. (1993) (107)
Extramural cross‐validation of the mayo primary biliary cirrhosis survival model establishes its generalizability (1989) (106)
INFLUENCE OF POSITIVE LYMPHOCYTE CROSSMATCH AND HLA MISMATCHING ON VANISHING BILE DUCT SYNDROME IN HUMAN LIVER ALLOGRAFTS (1988) (100)
Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms. (1999) (92)
Effect of calcium supplementation on serum cholesterol and blood pressure. A randomized, double-blind, placebo-controlled, clinical trial. (2000) (78)
Primary sclerosing cholangitis: value of cholangiography in determining the prognosis. (1991) (73)
Data Monitoring Committees in Clinical Trials: A Practical Perspective. (2003) (69)
Soluble interleukin-2 receptor level as an indicator of liver allograft rejection. (1989) (63)
Home-Based White Collar Employment: Lessons from the 1980 Census (1987) (61)
Goodness-of-fit and diagnostics for proportional hazards regression models. (1995) (58)
Fruits, vegetables, and adenomatous polyps: the Minnesota Cancer Prevention Research Unit case-control study. (2002) (57)
Clinical and statistical analyses of new and evolving therapies for primary biliary cirrhosis (1988) (56)
Colorectal epithelial cell proliferative kinetics and risk factors for colon cancer in sporadic adenoma patients. (1997) (49)
Sequential Sampling Based on the Observed Fisher Information to Guarantee The Accuracy of the Maximum Likelihood Estimator (1983) (49)
Testing Proportional Hazards (2000) (48)
Intraoperative blood loss and patient and graft survival in orthotopic liver transplantation: their relationship to clinical and laboratory data. (1989) (45)
Methodological findings and considerations in measuring colorectal epithelial cell proliferation in humans. (1997) (44)
Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region (2005) (38)
Forecasting demand for special telephone services: A case study (1990) (34)
Multiple Events per Subject (2000) (34)
Application of the Mayo primary biliary cirrhosis survival model to Mayo liver transplant patients. (1989) (30)
The effects of transformations and preliminary tests for non-linearity in regression. (1991) (30)
Patterns of failure after total laryngectomy for glottic carcinoma (1989) (28)
Modeling the Labeling Index Distribution: An Application of Functional Data Analysis (1995) (25)
Statistical analysis of proliferative index data in clinical trials. (1994) (24)
Influence Of Site Of Obstetric Care And Delivery On Pregnancy Management And Outcome (1988) (18)
Simple robust tests for scale differences in paired data (1994) (17)
Regression to the Mean, Murder Rates, and Shall-Issue Laws (2008) (17)
Piecewise exponential survival curves with smooth transitions. (1994) (16)
Evaluation of sampling strategies for modeling survival of uveal malignant melanoma. (2003) (15)
Personalized chronobiologic cybercare; other chronomics' progress by transdisciplinary cycles' congruences: Season's appreciations 2009 (2011) (14)
HPA axis abnormalities in depressed patients with normal response to the DST. (1988) (12)
Congruent biospheric and solar-terrestrial cycles (2011) (12)
Soluble interleukin 2 receptor level in liver allograft recipients: an indicator of rejection. (1989) (12)
Estimating the Survival and Hazard Functions (2000) (11)
Sequential maximum likelihood estimation with applications to logistic regression in case-control studies (1989) (10)
Association between survival time and ordinal covariates. (1994) (9)
Series of Irregular Observations: Forecasting and Model Building (1987) (8)
Amendments and Corrections: Proportional Hazards Tests and Diagnostics Based on Weighted Residuals (1995) (8)
Penalized Cox models and Frailty (1998) (8)
Residuals for Survival Analysis (2005) (7)
Quality control and the identification of vaccine responders using ELISA‐derived antibody data (2003) (6)
A prospective pilot study evaluating the effectiveness of secretory IgA measurements in bronchoalveolar lavage to detect non-small cell lung cancer. (1990) (6)
A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome (2007) (6)
Comparison of Numerical Algorithms for Bivariate Sequential Tests Based on Marginal Criteria (2003) (4)
Intrapartum Intervention And Delivery Outcome In Low-Risk Pregnancy (1991) (4)
Modeling survival data : extending the cox model : with 80 illustrations (2010) (3)
Predictors of blood pressure control in the convince trial (2004) (2)
Estimation of Cancer Drug Potencies and Relative Potencies from In Vitro Data (2005) (2)
DESIGN AND ANALYSIS OF IN VITRO EXPERIMENTS FOR COMBINATION CHEMOTHERAPY (2004) (2)
Outcomes with physician's choice of initial drug in convince (2004) (1)
Evaluating the form of nonsinusoidal variations. (2011) (1)
Sample size calculation in survival trials accounting for time-varying relationship between noncompliance and risk of outcome event (2006) (1)
Data analysis for clinical medicine: The quantitative approach to patient care in gastroenterology. Thomas C. Chalmers (ed.), international university press, Rome, 1988. no. of pages: XIV + 217. price: $49.00 (1990) (1)
Circadian variation in cardiovascular events among diabetics in the convince trial (2004) (1)
Dr. Meller and Associates Reply (2006) (0)
Evaluation of Staging Systems for Colorectal Cancer (1993) (0)
Factors in the choice of beta-blocker vs. diuretic for initial treatment of hypertension in convince (2004) (0)
P-414: Predictors of “lost-to-follow-up” status in the convince trial (2003) (0)

This paper list is powered by the following services:

Other Resources About Patricia Grambsch

en.wikipedia.org

What Schools Are Affiliated With Patricia Grambsch?

Patricia Grambsch is affiliated with the following schools: